[Therapy of diabetic nephropathy].
New pathophysiological insights in the last few years on the development of diabetic nephropathy have led to a change in therapeutic measures. The emphasis is put on preventive considerations for the insulin-dependent diabetic patient. Strict control of glycemia and the early use of an angiotensin-conversion inhibitor are of importance. Therapy of the manifest diabetic nephropathy is based on strict metabolic control combined with reduced protein intake. Furthermore, an often co-existing hypertension needs to be treated. Normotensive blood pressure should be obtained. ACE-inhibitors and Ca-antagonists have been proven to be very effective, although there seem to exist differences in the type of Ca-antagonists regarding effectiveness on albuminuria. The combination of ACE-inhibitors and Ca-antagonists seems to have an additional beneficial impact on albuminuria. A significant decrease in the loss of glomerular function and a decrease in albuminuria can be obtained by consistent consideration of these therapeutic strategies.